Biopreservation

Global Biopreservation Market to Reach US$9.1 Billion by 2032

The global market for Biopreservation estimated at US$2.9 Billion in the year 2025, is expected to reach US$9.1 Billion by 2032, growing at a CAGR of 17.6% over the analysis period 2025-2032. Equipment Offering, one of the segments analyzed in the report, is expected to record a 19.3% CAGR and reach US$4.6 Billion by the end of the analysis period. Growth in the Media Offering segment is estimated at 16.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$904.0 Million While China is Forecast to Grow at 23.7% CAGR

The Biopreservation market in the U.S. is estimated at US$904.0 Million in the year 2025. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2032 trailing a CAGR of 23.7% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.7% and 16.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.7% CAGR.

Global Biopreservation Market - Key Trends and Drivers Summarized

Biopreservation technologies play a crucial role in extending the functional lifespan of biological materials such as cells, tissues, and organs, essential for a broad range of medical and scientific applications. This field has experienced significant growth due to advancements in preservation methods, increased government and private funding for healthcare research, and a rising demand across various medical and research sectors. Particularly beneficial in the realms of immunotherapies, vaccine production, and enzyme technology, biopreservation helps address the growing incidence of chronic diseases by maintaining the viability and functionality of biological materials. Furthermore, the technology incorporates sophisticated tools like microarrays and predictive models which streamline the preservation processes, enhancing diagnosis and treatment capabilities, especially in critical areas such as cardiology and gynecology.

The application of biopreservation is particularly noteworthy in biobanking and regenerative medicine, sectors that heavily rely on these technologies for stem cell preservation and the manufacturing of cell therapies compliant with Good Manufacturing Practices (GMP). Biopreservation supports the intricate requirements of maintaining `living drugs` through their lifecycle, optimizing preservation media to meet regulatory standards and ensure successful commercialization. This is crucial in regenerative medicine where the viability of cell therapies must be maintained from collection through to administration. Moreover, low-temperature storage methods, like cryogenic and hypothermic storage, play a pivotal role in this regard by reducing metabolic rates and minimizing biochemical requirements, which is vital for preserving cellular function and integrity during storage.

Several growth drivers are propelling the biopreservation market, including technological advancements that improve the efficiency of biological material storage, the expansion of R&D in biotechnology and medicine, and the increasing prevalence of chronic diseases that necessitate advanced therapeutic solutions. The expansion of biobanks globally, which requires robust biopreservation to maintain the integrity of biological samples, along with significant governmental and private funding, further fuels this growth. Additionally, stringent regulatory requirements necessitate reliable biopreservation solutions to ensure that biologically derived therapeutic products are safe and effective for clinical use. Innovations like improved cryopreservation technologies and novel media formulations that enhance cell viability and recovery rates are also crucial. As the field evolves, the integration of these technological advancements with increased healthcare investments underscores the crucial role of biopreservation in advancing healthcare and research, promising continued expansion and innovation in the preservation and utilization of vital biological resources.

SCOPE OF STUDY:

The report analyzes the Biopreservation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Type (Biopreservation Media, Biopreservation Equipment); Biospecimen (Human Tissue Samples, Organs, Stem Cells, Other Biospecimens); Application (Therapeutic Applications, Research Applications, Clinical Trials, Other Applications); End-Use (Biobanks, Gene Banks, Hospitals, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

• Atlanta Biologicals, Inc.
• BioCision, LLC
• BioGenix, LLC
• BioLife Solutions, Inc.
• Biomatrica, Inc.
• LabVantage Solutions, Inc.
• Panasonic Corporation
• Qiagen, Inc.
• Thermo Fisher Scientific, Inc.
• VWR International LLC

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher. Show more